PC: Tecsys’ new survey shows that only 20% of healthcare leaders report having real-time visibility across pharmacy inventory ...

Instead of discovering a shortage at the point of care, that real-time usage and inventory trend allows the pharmacy teams to really see that risk earlier and adjust their sourcing, avoid those ...

In today’s Pharma Pulse, bipartisan lawmakers target PBM vertical integration, while pharma giants race to secure tariff-exempt pricing deals.

View the Pharmaceutical Commerce February 2026 issue in an interactive format.

According to Reuters, some of the pharma companies that were not on the receiving end of President Trump’s May executive order (EO) 2 are interested in pursuing separate agreements in order to avoid ...

NovoCare-linked pricing at Meijer includes $199/month for first two months on low-dose Wegovy/Ozempic pens if filled by March 31, 2026, then $349/month for most doses. Cost exposure varies by dose, ...

Rising recalls, tighter FDA enforcement, global supply chain dependencies, and rapid technology shifts are reshaping pharmaceutical quality and compliance—forcing manufacturers to rethink oversight, ...

Cell and gene therapies (CGTs) represent one of the most profound breakthroughs in modern medicine, offering the possibility ...

In today’s Pharma Pulse, the American College of Physicians issues a formal rejection of the term "provider," while Takeda partners with Iambic Therapeutics to accelerate small-molecule discovery ...

In today’s Pharma Pulse, the FDA issues a rare “Refusal-to-File" for Moderna’s influenza vaccine, while new research confirms GLP-1s act as potent tools against chronic inflammation.

Bandy: The statistics that we found within the survey is that four inc five, which is equivalent to about 79%, are saying that the drug shortages are what's causing the most disruption. We agree, drug ...